Concepedia

Justin A. Weldon

JA

Statistics

Publications

4

Citations

153

H-Index

4

Active since

2018

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

West Virginia University

Justin A. Weldon is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, prostate cancer, and prostate cancer hormone therapy.

ORCID

Publications per year

2018–2021

4

Publications

4

Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial

Eric Jonasch, Ian E. McCutcheon, Dan S. Gombos et al. · The Lancet Oncology · 2018 · 101 citations · Full text

, , +5

Neoadjuvant apalutamide (APA) plus leuprolide (LHRHa) with or without abiraterone (AA) in localized high-risk prostate cancer (LHRPC).

Eleni Efstathiou, Myrto Boukovala, Nicholas Spetsieris et al. · Journal of Clinical Oncology · 2020 · 18 citations

, , +17

Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer

Nicholas Spetsieris, Myrto Boukovala, Ioannis Alafis et al. · European Journal of Cancer · 2021 · 18 citations

, , +14

A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer

Nicholas Spetsieris, Myrto Boukovala, Justin A. Weldon et al. · Clinical Genitourinary Cancer · 2020 · 16 citations · Full text

, , +16

1–4 of 4